Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryCannabis
SectorMedical
Phone855-558-9333
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$60.79 million
Profitability
Miscellaneous
Employees1,033
OptionableOptionable
Canopy Growth (NYSE:CGC) Frequently Asked Questions
What is Canopy Growth's stock symbol?
Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC."
How were Canopy Growth's earnings last quarter?
Canopy Growth Corp (NYSE:CGC) posted its quarterly earnings data on Wednesday, November, 14th. The marijuana producer reported ($0.76) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.64. The marijuana producer had revenue of $23.30 million for the quarter, compared to analyst estimates of $59.10 million. Canopy Growth had a negative return on equity of 26.32% and a negative net margin of 503.14%. The firm's quarterly revenue was up 32.4% compared to the same quarter last year. View Canopy Growth's Earnings History.
When is Canopy Growth's next earnings date?
What price target have analysts set for CGC?
5 brokerages have issued 12 month price targets for Canopy Growth's stock. Their predictions range from $40.00 to $61.00. On average, they expect Canopy Growth's share price to reach $50.50 in the next year. This suggests a possible upside of 16.0% from the stock's current price. View Analyst Price Targets for Canopy Growth.
What is the consensus analysts' recommendation for Canopy Growth?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Canopy Growth.
Has Canopy Growth been receiving favorable news coverage?
Media headlines about CGC stock have been trending very positive on Tuesday, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Canopy Growth earned a news impact score of 3.2 on InfoTrie's scale. They also gave news stories about the marijuana producer a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future.
Who are some of Canopy Growth's key competitors?
Some companies that are related to Canopy Growth include Actelion (ALIOF), Tilray (TLRY), Aurora Cannabis (ACB), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Cronos Group (CRON), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Natural Alternatives International (NAII), China Jo-Jo Drugstores (CJJD), Mannatech (MTEX), Pharmacyte Biotech (PMCB), GLG Life Tech (GLGLF) and Cyanotech (CYAN).
Who are Canopy Growth's key executives?
Canopy Growth's management team includes the folowing people:
- Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)
- Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEO
- Mr. Timothy Rob Saunders, Exec. VP & CFO
- Mr. Rade Kovacevic, Sr. VP & MD
- Ms. Ann Gordon, VP of Corp. Fin.
Who are Canopy Growth's major shareholders?
Canopy Growth's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include QCI Asset Management Inc. NY (0.16%), USA Mutuals Advisors Inc. (0.01%), Virtu Financial LLC (0.00%), Dubuque Bank & Trust Co. (0.00%), G&S Capital LLC (0.00%) and Mercer Capital Advisers Inc. (0.00%).
Which institutional investors are selling Canopy Growth stock?
CGC stock was sold by a variety of institutional investors in the last quarter, including Virtu Financial LLC.
Which institutional investors are buying Canopy Growth stock?
CGC stock was purchased by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY, USA Mutuals Advisors Inc., G&S Capital LLC, Mercer Capital Advisers Inc., Dubuque Bank & Trust Co., TCI Wealth Advisors Inc., North Star Investment Management Corp. and Gradient Investments LLC.
How do I buy shares of Canopy Growth?
Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Canopy Growth's stock price today?
One share of CGC stock can currently be purchased for approximately $43.52.
How big of a company is Canopy Growth?
Canopy Growth has a market capitalization of $10.10 billion and generates $60.79 million in revenue each year. The marijuana producer earns $-54,880,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Canopy Growth employs 1,033 workers across the globe.
What is Canopy Growth's official website?
How can I contact Canopy Growth?
Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected]
MarketBeat Community Rating for Canopy Growth (NYSE CGC)
MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days.
